title: Adjuvant treatment of GIST with imatinib: solid ground or still quicksand? A comment on behalf of the EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group, the NCRI Sarcoma Clinical Studies Group (UK), the Japanese Study Group on GIST, the French Sarcoma Group and the Spanish Sarcoma Group (GEIS).
authors.affiliation: Sarcoma Unit, Department of Surgery, Istituto Nazionale Tumori, Via G. Venezian 1, 20133 Milano, Italy.
authors.forename: Alessandro
authors.initials: A
authors.lastname: Gronchi
authors.affiliation: The Institute of Cancer Research, Royal Cancer Hospital, 123 Old Brompton Road, London SW7 3RP, UK.
authors.forename: Ian
authors.initials: I
authors.lastname: Judson
authors.affiliation: Department of Surgery, E1, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
authors.forename: Toshirou
authors.initials: T
authors.lastname: Nishida
authors.affiliation: Medical Oncology Department, Fundacion Instituto Valenciano de Oncologia, Valencia, Spain.
authors.forename: Andres
authors.initials: A
authors.lastname: Poveda
authors.affiliation: Skeletal-Muscle Tumour Committee, Hospital Son Dureta, Palma de Mallorca, Spain.
authors.forename: Javier
authors.initials: J
authors.lastname: Martin
authors.affiliation: HELIOS Klinikum Bad Saarow, Pieskower Straße 33, 15526 Bad Saarow, Germany.
authors.forename: Peter
authors.initials: P
authors.lastname: Reichardt
authors.affiliation: Adult Sarcoma Medical Treatment Unit, Istituto Nazionale Tumori, Via G. Venezian 1, 20133 Milano, Italy.
authors.forename: Paolo G
authors.initials: PG
authors.lastname: Casali
authors.affiliation: Department of Medicine, Institut Gustave Roussy, 94805 Villejuif Cedex, France.
authors.forename: Axel Le
authors.initials: AL
authors.lastname: Cesne
authors.affiliation: Division of Surgical Oncology and Thoracic Surgery, Mannheim University Medical Centre, University of Heidelberg, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.
authors.forename: Peter
authors.initials: P
authors.lastname: Hohenberger
authors.affiliation: Department of Medicine, Centre Leon Berard, 28, rue Laennec, 69008 Lyon, France. Electronic address: blay@lyon.fnclcc.fr.
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Blay
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D017024:Chemotherapy, Adjuvant; D046152:Gastrointestinal Stromal Tumors / Q000188:drug therapy*; D006801:Humans; D000068877:Imatinib Mesylate; D010879:Piperazines / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012955:Societies, Medical; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate